
Join to view full profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-366-1164
Fax+1 614-293-7484
Dr. Grieselhuber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2014 - 2017
Ohio State University HospitalResidency, Internal Medicine, 2012 - 2015
WashU MedicineClass of 2012
Certifications & Licensure
OH State Medical License 2012 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 2 citationsBET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHD.Rathan Kumar, Lotus Neidemire-Colley, Elizabeth A R Garfinkle, Camryn Steere, Simran Surana
Blood. 2026-06-04 - Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML.Jayanshu Jain, Kelly Pugh, Shivani Handa, Kaitlyn M Dvorak-Kornaus, Qiuhong Zhao
Blood Neoplasia. 2026-02-01 - 1 citationsPKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia.Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, Janani Ravikrishnan, Arnau Peris-Cuesta
Blood Cancer Discovery. 2026-01-12
Abstracts/Posters
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationNicole Grieselhuber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- NPM1 mutations Using Deep Amplicon Sequencing and Broad Next Generation Sequencing at the Time of Complete Remission Is Informative to Predicting Risk of Relapse Follo...Nicole Grieselhuber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
How Targeted Drugs Can Vanquish a Virulent LeukemiaSeptember 29th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









